209 related articles for article (PubMed ID: 33802394)
1. Design of Topical Ocular Ciprofloxacin Nanoemulsion for the Management of Bacterial Keratitis.
Youssef AAA; Cai C; Dudhipala N; Majumdar S
Pharmaceuticals (Basel); 2021 Mar; 14(3):. PubMed ID: 33802394
[TBL] [Abstract][Full Text] [Related]
2. Design of Topical Moxifloxacin Mucoadhesive Nanoemulsion for the Management of Ocular Bacterial Infections.
Youssef AAA; Thakkar R; Senapati S; Joshi PH; Dudhipala N; Majumdar S
Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745818
[TBL] [Abstract][Full Text] [Related]
3. Dual Drug Loaded Lipid Nanocarrier Formulations for Topical Ocular Applications.
Youssef AAA; Dudhipala N; Majumdar S
Int J Nanomedicine; 2022; 17():2283-2299. PubMed ID: 35611213
[TBL] [Abstract][Full Text] [Related]
4. Ciprofloxacin Loaded Nanostructured Lipid Carriers Incorporated into In-Situ Gels to Improve Management of Bacterial Endophthalmitis.
Youssef A; Dudhipala N; Majumdar S
Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32575524
[TBL] [Abstract][Full Text] [Related]
5. Formulation and In Vitro-Ex vivo Evaluation of Cannabidiol and Cannabidiol-Valine-Hemisuccinate Loaded Lipid-Based Nanoformulations for Ocular Applications.
Adel Ali Youssef A; Hayder Abdelrahman M; Geweda MM; Varner C; Joshi PH; Ghonge M; Dudhipala N; Sulochana SP; Gadepalli RS; Majumdar S
Int J Pharm; 2024 May; 657():124110. PubMed ID: 38604539
[TBL] [Abstract][Full Text] [Related]
6. Effect of surfactant concentration and sterilization process on intraocular pressure-lowering activity of Δ
Sweeney C; Dudhipala N; Thakkar R; Mehraj T; Marathe S; Gul W; ElSohly MA; Murphy B; Majumdar S
Drug Deliv Transl Res; 2021 Oct; 11(5):2096-2107. PubMed ID: 33169348
[TBL] [Abstract][Full Text] [Related]
7. Development of Ciprofloxacin-Loaded Bilosomes In-Situ Gel for Ocular Delivery: Optimization, In-Vitro Characterization, Ex-Vivo Permeation, and Antimicrobial Study.
Alsaidan OA; Zafar A; Yasir M; Alzarea SI; Alqinyah M; Khalid M
Gels; 2022 Oct; 8(11):. PubMed ID: 36354595
[TBL] [Abstract][Full Text] [Related]
8. Investigation of moxifloxacin loaded chitosan-dextran nanoparticles for topical instillation into eye: In-vitro and ex-vivo evaluation.
Kaskoos RA
Int J Pharm Investig; 2014 Oct; 4(4):164-73. PubMed ID: 25426437
[TBL] [Abstract][Full Text] [Related]
9. Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability.
Patel N; Nakrani H; Raval M; Sheth N
Drug Deliv; 2016 Nov; 23(9):3712-3723. PubMed ID: 27689408
[TBL] [Abstract][Full Text] [Related]
10. Development of a Luliconazole Nanoemulsion as a Prospective Ophthalmic Delivery System for the Treatment of Fungal Keratitis: In Vitro and In Vivo Evaluation.
Yang J; Liang Z; Lu P; Song F; Zhang Z; Zhou T; Li J; Zhang J
Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297487
[TBL] [Abstract][Full Text] [Related]
11. Lornoxicam-Loaded Chitosan-Decorated Nanoemulsion: Preparation and In Vitro Evaluation for Enhanced Transdermal Delivery.
Khan RU; Shah SU; Rashid SA; Naseem F; Shah KU; Farid A; Hakeem KR; Kamli MR; Althubaiti EH; Alamoudi SA
Polymers (Basel); 2022 May; 14(9):. PubMed ID: 35567091
[TBL] [Abstract][Full Text] [Related]
12. Design and development of a novel pH triggered nanoemulsified in-situ ophthalmic gel of fluconazole: ex-vivo transcorneal permeation, corneal toxicity and irritation testing.
Pathak MK; Chhabra G; Pathak K
Drug Dev Ind Pharm; 2013 May; 39(5):780-90. PubMed ID: 22873799
[TBL] [Abstract][Full Text] [Related]
13. Chondroitin sulfate-chitosan nanoparticles for ocular delivery of bromfenac sodium: Improved permeation, retention, and penetration.
Abdullah TA; Ibrahim NJ; Warsi MH
Int J Pharm Investig; 2016; 6(2):96-105. PubMed ID: 27051629
[TBL] [Abstract][Full Text] [Related]
14. Ocular disposition of ciprofloxacin from topical, PEGylated nanostructured lipid carriers: Effect of molecular weight and density of poly (ethylene) glycol.
Balguri SP; Adelli GR; Janga KY; Bhagav P; Majumdar S
Int J Pharm; 2017 Aug; 529(1-2):32-43. PubMed ID: 28634139
[TBL] [Abstract][Full Text] [Related]
15. Central Composite Design Implemented Azilsartan Medoxomil Loaded Nanoemulsion to Improve Its Aqueous Solubility and Intestinal Permeability: In Vitro and Ex Vivo Evaluation.
Kumar G; Virmani T; Pathak K; Kamaly OA; Saleh A
Pharmaceuticals (Basel); 2022 Oct; 15(11):. PubMed ID: 36355515
[TBL] [Abstract][Full Text] [Related]
16. Formulation development and in Vitro-Ex vivo characterization of hot-melt extruded ciprofloxacin hydrochloride inserts for ocular applications: Part I.
Alzahrani A; Adel Ali Youssef A; Senapati S; Tripathi S; Bandari S; Majumdar S; Repka MA
Int J Pharm; 2023 Jan; 630():122423. PubMed ID: 36427695
[TBL] [Abstract][Full Text] [Related]
17. Development and optimization of hot-melt extruded moxifloxacin hydrochloride inserts, for ocular applications, using the design of experiments.
Thakkar R; Komanduri N; Dudhipala N; Tripathi S; Repka MA; Majumdar S
Int J Pharm; 2021 Jun; 603():120676. PubMed ID: 33961956
[TBL] [Abstract][Full Text] [Related]
18. Nanoemulsion Based Vehicle for Effective Ocular Delivery of Moxifloxacin Using Experimental Design and Pharmacokinetic Study in Rabbits.
Shah J; Nair AB; Jacob S; Patel RK; Shah H; Shehata TM; Morsy MA
Pharmaceutics; 2019 May; 11(5):. PubMed ID: 31083593
[TBL] [Abstract][Full Text] [Related]
19. Formulation of Chitosan Polymeric Vesicles of Ciprofloxacin for Ocular Delivery: Box-Behnken Optimization, In Vitro Characterization, HET-CAM Irritation, and Antimicrobial Assessment.
Ameeduzzafar ; Alruwaili NK; Imam SS; Alotaibi NH; Alhakamy NA; Alharbi KS; Alshehri S; Afzal M; Alenezi SK; Bukhari SNA
AAPS PharmSciTech; 2020 Jun; 21(5):167. PubMed ID: 32504176
[TBL] [Abstract][Full Text] [Related]
20. Cubogel as potential platform for glaucoma management.
Sayed S; Abdel-Moteleb M; Amin MM; Khowessah OM
Drug Deliv; 2021 Dec; 28(1):293-305. PubMed ID: 33509004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
